Cargando…
SARS-CoV-2 Multi-Antigen Serology Assay
Serology tests are extremely useful for assessing whether a person has been infected with a pathogen. Since the onset of the COVID-19 pandemic, measurement of anti-SARS-CoV-2-specific antibodies has been considered an essential tool in identifying seropositive individuals and thereby understanding t...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544427/ https://www.ncbi.nlm.nih.gov/pubmed/34698238 http://dx.doi.org/10.3390/mps4040072 |
_version_ | 1784589814236971008 |
---|---|
author | Mazhari, Ramin Ruybal-Pesántez, Shazia Angrisano, Fiona Kiernan-Walker, Nicholas Hyslop, Stephanie Longley, Rhea J. Bourke, Caitlin Chen, Catherine Williamson, Deborah A. Robinson, Leanne J. Mueller, Ivo Eriksson, Emily M. |
author_facet | Mazhari, Ramin Ruybal-Pesántez, Shazia Angrisano, Fiona Kiernan-Walker, Nicholas Hyslop, Stephanie Longley, Rhea J. Bourke, Caitlin Chen, Catherine Williamson, Deborah A. Robinson, Leanne J. Mueller, Ivo Eriksson, Emily M. |
author_sort | Mazhari, Ramin |
collection | PubMed |
description | Serology tests are extremely useful for assessing whether a person has been infected with a pathogen. Since the onset of the COVID-19 pandemic, measurement of anti-SARS-CoV-2-specific antibodies has been considered an essential tool in identifying seropositive individuals and thereby understanding the extent of transmission in communities. The Luminex system is a bead-based technology that has the capacity to assess multiple antigens simultaneously using very low sample volumes and is ideal for high-throughput studies. We have adapted this technology to develop a COVID-19 multi-antigen serological assay. This protocol described here carefully outlines recommended steps to optimize and establish this method for COVID-19-specific antibody measurement in plasma and in saliva. However, the protocol can easily be customized and thus the assay is broadly applicable to measure antibodies to other pathogens. |
format | Online Article Text |
id | pubmed-8544427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85444272021-10-26 SARS-CoV-2 Multi-Antigen Serology Assay Mazhari, Ramin Ruybal-Pesántez, Shazia Angrisano, Fiona Kiernan-Walker, Nicholas Hyslop, Stephanie Longley, Rhea J. Bourke, Caitlin Chen, Catherine Williamson, Deborah A. Robinson, Leanne J. Mueller, Ivo Eriksson, Emily M. Methods Protoc Protocol Serology tests are extremely useful for assessing whether a person has been infected with a pathogen. Since the onset of the COVID-19 pandemic, measurement of anti-SARS-CoV-2-specific antibodies has been considered an essential tool in identifying seropositive individuals and thereby understanding the extent of transmission in communities. The Luminex system is a bead-based technology that has the capacity to assess multiple antigens simultaneously using very low sample volumes and is ideal for high-throughput studies. We have adapted this technology to develop a COVID-19 multi-antigen serological assay. This protocol described here carefully outlines recommended steps to optimize and establish this method for COVID-19-specific antibody measurement in plasma and in saliva. However, the protocol can easily be customized and thus the assay is broadly applicable to measure antibodies to other pathogens. MDPI 2021-10-09 /pmc/articles/PMC8544427/ /pubmed/34698238 http://dx.doi.org/10.3390/mps4040072 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Protocol Mazhari, Ramin Ruybal-Pesántez, Shazia Angrisano, Fiona Kiernan-Walker, Nicholas Hyslop, Stephanie Longley, Rhea J. Bourke, Caitlin Chen, Catherine Williamson, Deborah A. Robinson, Leanne J. Mueller, Ivo Eriksson, Emily M. SARS-CoV-2 Multi-Antigen Serology Assay |
title | SARS-CoV-2 Multi-Antigen Serology Assay |
title_full | SARS-CoV-2 Multi-Antigen Serology Assay |
title_fullStr | SARS-CoV-2 Multi-Antigen Serology Assay |
title_full_unstemmed | SARS-CoV-2 Multi-Antigen Serology Assay |
title_short | SARS-CoV-2 Multi-Antigen Serology Assay |
title_sort | sars-cov-2 multi-antigen serology assay |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544427/ https://www.ncbi.nlm.nih.gov/pubmed/34698238 http://dx.doi.org/10.3390/mps4040072 |
work_keys_str_mv | AT mazhariramin sarscov2multiantigenserologyassay AT ruybalpesantezshazia sarscov2multiantigenserologyassay AT angrisanofiona sarscov2multiantigenserologyassay AT kiernanwalkernicholas sarscov2multiantigenserologyassay AT hyslopstephanie sarscov2multiantigenserologyassay AT longleyrheaj sarscov2multiantigenserologyassay AT bourkecaitlin sarscov2multiantigenserologyassay AT chencatherine sarscov2multiantigenserologyassay AT williamsondeboraha sarscov2multiantigenserologyassay AT robinsonleannej sarscov2multiantigenserologyassay AT muellerivo sarscov2multiantigenserologyassay AT erikssonemilym sarscov2multiantigenserologyassay |